Evonik Industries AG (EVK.DE), a German chemicals company, on Friday posted a decline in net income and sales for the first quarter of fiscal 2026.
For the three-month period, the company reported a net profit of EUR 125 million, less than EUR 233 million in the same period last year. Excluding items, income stood at EUR 158 million as against EUR 275 million a year ago. Adjusted EBITDA was EUR 475 million, down from EUR 560 million in the previous year.
Evonik reported sales of EUR 3.427 billion, less than EUR 3.777 billion last year. This decline in sales reflects unfavorable exchange rates, a 2% drop in sales volumes, and a 1% fall in prices.
Looking ahead, for the second quarter, the company expects a rise in adjusted EBITDA due to higher sales volumes in certain businesses as a result of the persisting conflict in the Middle East.
For the second quarter of fiscal 2026, Evonik anticipates adjusted EBITDA of EUR 550 million. For the second quarter of fiscal 2025, the company had recorded an adjusted EBITDA of EUR 509 million.
For fiscal 2026, Evonik has reaffirmed its adjusted EBITDA outlook of EUR 1.7 billion to EUR 2 billion.
For fiscal 2025, the company had posted adjusted EBITDA of EUR 1.87 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.